Component E-H Implants With Tylan 20 mg Implant is a Health Canada–registered veterinary drug (DIN 02245746) held by Elanco Canada Limited, containing Estradiol Benzoate. Health Canada lists its status as Marketed (status date 14 Feb 2018). Nexara Health has matched 29 registrations of Estradiol Benzoate across 2 other regulated markets.
Health Canada registration
| DIN | 02245746 |
|---|---|
| Brand name | Component E-H Implants With Tylan |
| Active ingredient | Estradiol Benzoate |
| Strength | 20 mg |
| Dosage form | Implant |
| Route | Subcutaneous |
| Company | Elanco Canada Limited |
| Status | Marketed — 14 Feb 2018 |
| Class | Veterinary |
| ATC | |
| AHFS | |
| Regulator record | Health Canada DPD entry · Product monograph |
Estradiol Benzoate registered in other markets
29 registrations of the same molecule in 2 national registries outside Canada (first 11 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| Taiwan | Eremon Injection | 聯邦化學製藥股份有限公司 | 注射劑 | 已註銷 | TFDA | |
| Taiwan | Eshormon Injection | 新喜國際企業股份有限公司 | 注射劑 | 已註銷 | TFDA | |
| Taiwan | Eshormon Suspended Injection "T.s." | 德星製藥廠有限公司 | 滅菌懸液注射劑 | 已註銷 | TFDA | |
| Taiwan | Estradiol Benzoate | Roussel Uclaf | （粉） | 已註銷 | TFDA | |
| Taiwan | Estradiol Benzoate | Aventis Pharma S.a. | （粉） | 已註銷 | TFDA | |
| Taiwan | Estradiol Benzoate | Roussel Uclaf | （粉） | 已註銷 | TFDA | |
| Taiwan | Estradiol Benzoate | Bayer AG | （粉） | 已註銷 | TFDA | |
| Taiwan | Estradiol Benzoate "Diosynth" | Diosynth B.v. | （粉） | 已註銷 | TFDA | |
| United States | estradiol benzoate | zhejiang xianju pharmaceutical co., Ltd. | Powder | FDA NDC | ||
| United States | Estradiol benzoate | Bayer AG | Powder | FDA NDC | ||
| United States | Estradiol benzoate | Valdepharm | Powder | FDA NDC |
See every manufacturer of Estradiol Benzoate worldwide →
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. Because this DIN is marketed in Canada, supply normally comes through the Canadian channel; where the Canadian presentation is short or discontinued, the registrations above show which regulated markets hold an equivalent that can be imported under the Special Access Programme or for clinical comparator use. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Component E-H Implants With Tylan (DIN 02245746) marketed in Canada?
Yes. Health Canada lists DIN 02245746 as Marketed as of 14 Feb 2018.
Who holds the Canadian licence for this product?
Elanco Canada Limited is the company of record in the Health Canada Drug Product Database.
Is Estradiol Benzoate registered outside Canada?
Yes — Nexara Health has matched 29 registrations in 2 other markets (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 02245746, status date 2018-02-14; national medicine registries: FDA NDC, TFDA. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 02245746, status date 2018-02-14; national medicine registries: FDA NDC, TFDA.
Health Canada Drug Product Database (DPD), DIN 02245746, status date 2018-02-14; national medicine registries: FDA NDC, TFDA. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.